These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8931840)

  • 1. Sodium lithium countertransport and blood pressure. Longitudinal findings.
    Trevisan M; Strazzullo P; Cappuccio F; Jossa F; Iacone R; Russo I; Farinaro E
    Am J Hypertens; 1996 Nov; 9(11):1132-5. PubMed ID: 8931840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study.
    Strazzullo P; Siani A; Cappuccio FP; Trevisan M; Ragone E; Russo L; Iacone R; Farinaro E
    Hypertension; 1998 Jun; 31(6):1284-9. PubMed ID: 9622143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study.
    Laurenzi M; Cirillo M; Panarelli W; Trevisan M; Stamler R; Dyer AR; Stamler J
    Circulation; 1997 Feb; 95(3):581-7. PubMed ID: 9024143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
    Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
    Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.
    Hunt SC; Williams RR; Ash KO
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():357-62. PubMed ID: 2271398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between sodium-lithium countertransport and insulin sensitivity in mild hypertension.
    Herlitz H; Landin K; Widgren B
    J Intern Med; 1996 Mar; 239(3):235-40. PubMed ID: 8772622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-lithium countertransport and blood pressure change over time: the Gubbio study.
    Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Dyer AR; Stamler R; Stamler J
    Hypertension; 1996 Jun; 27(6):1305-11. PubMed ID: 8641740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological Study. The Gubbio Collaborative Study Group.
    Trevisan M; Laurenzi M
    Circulation; 1991 Nov; 84(5):2011-9. PubMed ID: 1934375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Na-Li countertransport and risk of hypertension in children: a 10-year prospective study in Hanzhong children.
    Mu J; Liu Z; Yang D; Liang Y; Wang Z; Hou R
    J Hum Hypertens; 2004 Dec; 18(12):885-90. PubMed ID: 15269707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group.
    Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Stamler J
    Hypertension; 1999 Mar; 33(3):887-93. PubMed ID: 10082504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-lithium countertransport and body fat distribution.
    Trevisan M; Strazzullo P; Cappuccio FP; Farinaro E; Jossa F; Krogh V; Iacone R; Mancini M
    Life Sci; 1992; 51(9):687-93. PubMed ID: 1501513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA
    Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
    Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-lithium countertransport and systolic blood pressure response to exercise.
    McDonald AM; Liao YL; Trevisan M; Dyer A; Gosch FC; Stamler R; Stamler J
    J Hypertens; 1990 Feb; 8(2):129-37. PubMed ID: 2162875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-lithium countertransport is not a marker of proximal tubular sodium clearance.
    Maling TJ; Siebers RW
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S50-1. PubMed ID: 1708024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers.
    Strazzullo P; Cappuccio FP; Trevisan M; Siani A; Barba G; Ragone E; Pagano E; Mancini M
    J Hypertens; 1993 Aug; 11(8):815-22. PubMed ID: 8228205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte sodium/lithium countertransport and renal lithium clearance in a random sample of untreated middle-aged men.
    Strazzullo P; Cappuccio FP; Trevisan M; Iacoviello L; Iacone R; Jossa F; Giorgione N; Farinaro E; Mancini M
    Clin Sci (Lond); 1989 Sep; 77(3):337-42. PubMed ID: 2805596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary versus pharmacological correction of hypertriglyceridemia on red blood cell membrane sodium/lithium countertransport activity.
    Pagano E; Siani A; Pauciullo P; Lirato C; Iacone R; Sacchi A; Strazzullo P
    Life Sci; 1997; 60(26):2389-97. PubMed ID: 9199483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls.
    Goulas A; Kosmidou M; Hatzitolios AI; Raikos N; Molyva D; Savopoulos C; Giannopoulos S; Fidani L
    Clin Chem Lab Med; 2008; 46(3):306-10. PubMed ID: 18254710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.